UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness of mindfulness-based interventions for people with dementia and mild cognitive impairment: A meta-analysis and implications for future research

PloS one, 2021-08, Vol.16 (8), p.e0255128-e0255128

2021

Volltextzugriff (PDF)

Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms

Schizophrenia research, 2020-01, Vol.215, p.8-16

2020

Volltextzugriff (PDF)

Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

Schizophrenia bulletin, 2017-07, Vol.43 (4), p.764-777

2017

Volltextzugriff (PDF)

Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms

Schizophrenia research, 2021-10, Vol.236, p.142-155

2021

Volltextzugriff (PDF)

Pathophysiology, prognosis and treatment of tardive dyskinesia

Therapeutic Advances in Psychopharmacology, 2022, Vol.12, p.20451253221117313

2022

Volltextzugriff (PDF)

Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms

Schizophrenia research, 2012-02, Vol.134 (2), p.219-225

2012

Volltextzugriff (PDF)

Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis

Schizophrenia bulletin, 2017-01, Vol.43 (4), p.sbw171-871

2017

Volltextzugriff (PDF)

Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis

Schizophrenia bulletin, 2020-12, Vol.46 (6), p.1439-1458

2020

Volltextzugriff (PDF)

Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis

Schizophrenia research, 2018-03, Vol.193, p.29-36

2018

Volltextzugriff (PDF)

One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis

British journal of psychiatry, 2017-09, Vol.211 (3), p.137-143

2017

Volltextzugriff (PDF)

Incidence of Antipsychotic-Associated Side Effects: Impact of Clinician Versus Patient Ratings and Change Versus Absolute Scores

Journal of clinical psychopharmacology, 2016-12, Vol.36 (6), p.593-596

2016

Volltextzugriff (PDF)

Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan

Therapeutic Advances in Psychopharmacology, 2022-01, Vol.12, p.20451253221139608-20451253221139608

2022

Volltextzugriff (PDF)

Treating Negative Symptoms in Schizophrenia: an Update

Current treatment options in psychiatry, 2016, Vol.3 (2), p.133-150

2016

Volltextzugriff (PDF)

The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophrenia

International clinical psychopharmacology, 2023-05, Vol.38 (3), p.182-183

Takeuchi, Hiroyoshi

2023

Volltextzugriff (PDF)

Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia

Psychiatry research, 2015-06, Vol.227 (2), p.265-269

2015

Volltextzugriff (PDF)

Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis

Schizophrenia bulletin, 2011-07, Vol.37 (4), p.788-799

2011

Volltextzugriff (PDF)

Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials

Neuropsychopharmacology (New York, N.Y.), 2020-04, Vol.45 (5), p.902-902

2020

Volltextzugriff (PDF)

Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)

PloS one, 2020-06, Vol.15 (6), p.e0234864-e0234864

2020

Volltextzugriff (PDF)

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms

Human psychopharmacology, 2021-11, Vol.36 (6), p.e2804-n/a

2021

Volltextzugriff (PDF)

A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)

Journal of psychiatric research, 2016-09, Vol.80, p.87-92

2016

Volltextzugriff (PDF)

Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms

Canadian journal of psychiatry, 2015-11, Vol.60 (11), p.515-522

2015

Volltextzugriff (PDF)

Neurocognitive impairment in the deficit subtype of schizophrenia

European archives of psychiatry and clinical neuroscience, 2016-08, Vol.266 (5), p.397-407

2016

Volltextzugriff (PDF)

Relationship between regional gray matter volumes and dopamine D2 receptor and transporter in living human brains

Human brain mapping, 2021-05, Vol.42 (12), p.4048-4058

2021

Volltextzugriff (PDF)

More options, more value: a new long-acting injectable formulation of risperidone

The Lancet. Psychiatry, 2023-12, Vol.10 (12), p.911-913

Takeuchi, Hiroyoshi

2023

Volltextzugriff (PDF)

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

The journal of clinical psychiatry, 2024-03, Vol.85 (2)

2024

Volltextzugriff (PDF)

1 – 25 von 398

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(314)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(231)
Life Sciences & Biomedicine
(213)
Humans
(153)
Psychiatry
(132)
Male
(84)
Female
(79)
Adult
(72)
Schizophrenia
(71)
Middle Aged
(65)
Schizophrenia - Drug Therapy
(58)
Pharmacology & Pharmacy
(43)
Aged
(39)
Antipsychotics
(36)
Antipsychotic Agents - Therapeutic Use
(34)
Biological And Medical Sciences
(34)
Gastroenterology & Hepatology
(29)
Medical Sciences
(29)
Schizophrenic Psychology
(28)
Treatment Outcome
(28)
Antipsychotic Agents - Administration & Dosage
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Effectiveness of mindfulness-based interventions for people with dementia and mild cognitive impairment: A meta-analysis and implications for future research

Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms

Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms

Pathophysiology, prognosis and treatment of tardive dyskinesia

Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms

Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis

Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis

Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis

One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis

Incidence of Antipsychotic-Associated Side Effects: Impact of Clinician Versus Patient Ratings and Change Versus Absolute Scores

Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan

Treating Negative Symptoms in Schizophrenia: an Update

The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophrenia

Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia

Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis

Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials

Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms

A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)

Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms

Neurocognitive impairment in the deficit subtype of schizophrenia

Relationship between regional gray matter volumes and dopamine D2 receptor and transporter in living human brains

More options, more value: a new long-acting injectable formulation of risperidone

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

Aktive Filter

Suchergebnisse filtern